Faraday Pharmaceuticals Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$1.65M
- Investors
-
7
Faraday Pharmaceuticals General Information
Description
Developer of novel therapeutics designed to offer elemental reducing agents. The company's therapeutics are focused on the ability of specific reduced forms of elements to improve outcomes for patients, enabling medical practitioners to treat ischemia-reperfusion injury and other critical care illnesses in a simplified manner.
Contact Information
Website
www.faradaypharma.comCorporate Office
- 1616 Eastlake Avenue East
- Suite 560
- Seattle, WA 98102
- United States
Corporate Office
- 1616 Eastlake Avenue East
- Suite 560
- Seattle, WA 98102
- United States
Faraday Pharmaceuticals Timeline
Faraday Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Debt - General | 01-Jan-2024 | $1.65M | Completed | Clinical Trials - Phase 3 | ||
| 4. Debt - General | 01-Jan-2023 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC (Series C) | 07-Nov-2022 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series B) | 12-Sep-2019 | $30.1M | $62.7M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC (Series A) | 21-Feb-2017 | $32.6M | $32.6M | Completed | Startup |
Faraday Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 21,872,076 | $0.000100 | 8% | $1.31 | $1.31 | 1x | $1.31 | 12.3% |
| Series A | 32,775,844 | $0.000100 | 8% | $1 | $1 | 1x | $1 | 18.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Faraday Pharmaceuticals Comparisons
Industry
Financing
Details
Faraday Pharmaceuticals Competitors (75)
One of Faraday Pharmaceuticals’s 75 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| EyePoint | Corporation | Watertown, MA | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Amryt Pharma | Corporate Backed or Acquired | London, United Kingdom |
Faraday Pharmaceuticals Patents
Faraday Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025222169-A1 | S-oxprenolol for preserving muscle mass, bone density, and cardiac function in weight loss treatments | Pending | 19-Apr-2024 | ||
| WO-2025222169-A9 | S-oxprenolol for preserving muscle mass, bone density, and cardiac function in weight loss treatments | Pending | 19-Apr-2024 | ||
| GB-202301180-D0 | Salt of a pharmaceutical compound | Inactive | 27-Jan-2023 | ||
| AU-2024212388-A1 | Salt of s-oxprenolol | Pending | 27-Jan-2023 | ||
| EP-4441028-A1 | Salt of s-oxprenolol | Active | 27-Jan-2023 | A61K31/138 |
Faraday Pharmaceuticals Signals
Faraday Pharmaceuticals Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The University of Tokyo Edge Capital | Venture Capital | Minority | ||
| 5AM Ventures | Venture Capital | Minority | ||
| Alexandria Real Estate Equities | Real Estate | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Osage University Partners | Venture Capital | Minority |
Faraday Pharmaceuticals FAQs
-
When was Faraday Pharmaceuticals founded?
Faraday Pharmaceuticals was founded in 2014.
-
Where is Faraday Pharmaceuticals headquartered?
Faraday Pharmaceuticals is headquartered in Seattle, WA.
-
What is the size of Faraday Pharmaceuticals?
Faraday Pharmaceuticals has 27 total employees.
-
What industry is Faraday Pharmaceuticals in?
Faraday Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Faraday Pharmaceuticals a private or public company?
Faraday Pharmaceuticals is a Private company.
-
What is Faraday Pharmaceuticals’s current revenue?
The current revenue for Faraday Pharmaceuticals is .
-
How much funding has Faraday Pharmaceuticals raised over time?
Faraday Pharmaceuticals has raised $120M.
-
Who are Faraday Pharmaceuticals’s investors?
The University of Tokyo Edge Capital, 5AM Ventures, Alexandria Real Estate Equities, ARCH Venture Partners, and Osage University Partners are 5 of 7 investors who have invested in Faraday Pharmaceuticals.
-
Who are Faraday Pharmaceuticals’s competitors?
Renova Therapeutics, EyePoint, Ardelyx, Pacira BioSciences, and Amryt Pharma are some of the 75 competitors of Faraday Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process